Günter Emons - Gynecology

Author Information

Günter Emons is a prominent researcher affiliated with the Department of Obstetrics and Gynecology at Georg August University in Göttingen, Germany. His extensive work in the field of gynecology has made significant contributions to our understanding of various conditions and treatments related to women's health.

Research Contributions

Günter Emons has an extensive publication record that includes research on ovarian and endometrial cancers, hormone replacement therapy, cancer screening, and perimenopause and postmenopause interventions. Some notable publications from 2021 include studies on the role of Gonadotropin-Releasing Hormone (GnRH) in ovarian and endometrial cancers, hormone replacement therapy in BRCA mutation carriers, and guidelines for perimenopause and postmenopause diagnosis and interventions. His work has also explored risk-adjusted cancer screening and the mortality associated with esophagectomy for esophageal cancer across different income countries.

Aliases

Günter Emons is also known by several aliases including Günter Emons, Gu Nter Emons, Gunter Emons, and G Emons.

Publication and Citation Metrics

Metric	Value
Citation Count	8880
H-Index	51
Paper Count	306

Publications:

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer

DOI: 10.3390/cells10020437

Year: 2021

Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)

DOI: 10.1136/ijgc-2021-002703

Year: 2021

Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors

DOI: 10.1159/000517182

Year: 2021

The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer

DOI: 10.3390/cells10020292

Year: 2021

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

DOI: 10.1007/s00432-021-03629-z

Year: 2021

Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020).

DOI: 10.1055/a-1361-1948

Year: 2021

Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study.

DOI: 10.1016/j.ejso.2020.12.006

Year: 2021

Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG) zur Lancet-Studie „Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence“ (29. August 2019; doi:10.1016/S0140-6736(19)3

DOI: 10.1055/A-1102-4436

Year: 2021

Risk for breast and ovarian cancer modified by the use of oral contraceptives in BRCA1/2 mutation carriers

DOI: 10.1055/s-0040-1710691

Year: 2020

Lynch-Syndrom (HNPCC‑Syndrom)

DOI: 10.1007/s00129-020-04686-0

Year: 2020

What is Systemic Abuse in Gynecology?

What role does patient management play in reducing surgical complications?

How is Hormonal Testing Conducted?

What Can You Do to Maintain a Healthy Lipid Profile?

What Services Are Provided?

What is the Prognosis for Patients with Peripheral Neuropathy?

How Does Zinc Affect Female Reproductive Health?

How does Ulipristal Acetate work?

How Common are Congenital Anomalies in Gynecology?

How Effective is PGT-M?

Partnered Content Networks

Relevant Topics